findmyKOL

Rasih Ener, MD

Basic profile

Temple University

ORCIDNone on fileNPI
RegionPhiladelphia, PA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2015findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2015Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Rasih Ener is a Cardiology physician affiliated with Temple University. OpenAlex indexes 9 publications with 438 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9publications

Distinct works indexed by OpenAlex.

438citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.6%
    ACE inhibitor27.5%
    Lisinopril65%Lisinopril-Hydrochlorothiazide35%
    Part D<11 patients
    Statin23.6%
    Atorvastatin Calcium71%Rosuvastatin Calcium29%
    Part D<11 patients

    + 3 more classes in this area

  • Blood & clotting

    12.4%
    Factor Xa inhibitor12.4%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

  • PARADOKSİKAL MİYOKARD İNFARKTÜSU TEKRAR ZİYARETTE

    DergiPark (Istanbul University)

    2015
  • Risk of thrombogenicity among nonionic radiocontrast agents.

    PubMed

    2008
  • Carotid artery in-stent restenosis after carotid artery stenting.

    PubMed

    2008
  • HIV disease in thrombocardiology.

    PubMed

    2007
  • Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors.

    PubMed

    2006
4 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”